Exclusion of patients with brain metastases from cancer clinical trials

Roshal R. Patel; Vivek Verma; Austin B. Miller; Timothy A. Lin; Amit Jethanandani; Andres F. Espinoza; Walker Mainwaring; Alexander Augustyn; C. David Fuller; Erik P. Sulman; Debra N. Yeboa; Caroline C. Chung; Mary Frances McAleer; Jing Li; Daniel Yoshor; John F. De Groot; Jacob J. Mandel; Ethan B. Ludmir

doi:10.1093/neuonc/noz246

Exclusion of patients with brain metastases from cancer clinical trials

Roshal R. Patel, Vivek Verma, Austin B. Miller, Timothy A. Lin, Amit Jethanandani, Andres F. Espinoza, Walker Mainwaring, Alexander Augustyn, C. David Fuller, Erik P. Sulman, Debra N. Yeboa, Caroline C. Chung, Mary Frances McAleer, Jing Li, Daniel Yoshor, John F. De Groot, Jacob J. Mandel, Ethan B. Ludmir

Research output: Contribution to journal › Letter › peer-review

16 Scopus citations

Original language	English (US)
Pages (from-to)	577-579
Number of pages	3
Journal	Neuro-oncology
Volume	22
Issue number	4
DOIs	https://doi.org/10.1093/neuonc/noz246
State	Published - Apr 15 2020

ASJC Scopus subject areas

Oncology
Clinical Neurology
Cancer Research

Access to Document

10.1093/neuonc/noz246

Cite this

Patel, R. R., Verma, V., Miller, A. B., Lin, T. A., Jethanandani, A., Espinoza, A. F., Mainwaring, W., Augustyn, A., David Fuller, C., Sulman, E. P., Yeboa, D. N., Chung, C. C., McAleer, M. F., Li, J., Yoshor, D., De Groot, J. F., Mandel, J. J., & Ludmir, E. B. (2020). Exclusion of patients with brain metastases from cancer clinical trials. Neuro-oncology, 22(4), 577-579. https://doi.org/10.1093/neuonc/noz246

Patel, RR, Verma, V, Miller, AB, Lin, TA, Jethanandani, A, Espinoza, AF, Mainwaring, W, Augustyn, A, David Fuller, C, Sulman, EP, Yeboa, DN , Chung, CC , McAleer, MF , Li, J, Yoshor, D, De Groot, JF, Mandel, JJ & Ludmir, EB 2020, 'Exclusion of patients with brain metastases from cancer clinical trials', Neuro-oncology, vol. 22, no. 4, pp. 577-579. https://doi.org/10.1093/neuonc/noz246

@article{84e32a81cb8d4453a4ef7a06c36e0bd8,

title = "Exclusion of patients with brain metastases from cancer clinical trials",

author = "Patel, {Roshal R.} and Vivek Verma and Miller, {Austin B.} and Lin, {Timothy A.} and Amit Jethanandani and Espinoza, {Andres F.} and Walker Mainwaring and Alexander Augustyn and {David Fuller}, C. and Sulman, {Erik P.} and Yeboa, {Debra N.} and Chung, {Caroline C.} and McAleer, {Mary Frances} and Jing Li and Daniel Yoshor and {De Groot}, {John F.} and Mandel, {Jacob J.} and Ludmir, {Ethan B.}",

note = "Funding Information: relevant financial disclosures or conflicts of interest. Outside of the submitted work, CDF reports institutional grants from the National Institutes of Health, GE Healthcare, Elekta AB, and National Science Foundation. CCC reports grants from Siemens Healthineers and RaySearch Laboratories. JJM serves on the medical advisory board for Bayer Pharmaceuticals.",

year = "2020",

month = apr,

day = "15",

doi = "10.1093/neuonc/noz246",

language = "English (US)",

volume = "22",

pages = "577--579",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Exclusion of patients with brain metastases from cancer clinical trials

AU - Patel, Roshal R.

AU - Verma, Vivek

AU - Miller, Austin B.

AU - Lin, Timothy A.

AU - Jethanandani, Amit

AU - Espinoza, Andres F.

AU - Mainwaring, Walker

AU - Augustyn, Alexander

AU - David Fuller, C.

AU - Sulman, Erik P.

AU - Yeboa, Debra N.

AU - Chung, Caroline C.

AU - McAleer, Mary Frances

AU - Li, Jing

AU - Yoshor, Daniel

AU - De Groot, John F.

AU - Mandel, Jacob J.

AU - Ludmir, Ethan B.

N1 - Funding Information: relevant financial disclosures or conflicts of interest. Outside of the submitted work, CDF reports institutional grants from the National Institutes of Health, GE Healthcare, Elekta AB, and National Science Foundation. CCC reports grants from Siemens Healthineers and RaySearch Laboratories. JJM serves on the medical advisory board for Bayer Pharmaceuticals.

PY - 2020/4/15

Y1 - 2020/4/15

UR - http://www.scopus.com/inward/record.url?scp=85083544787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083544787&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noz246

DO - 10.1093/neuonc/noz246

M3 - Letter

C2 - 31900480

AN - SCOPUS:85083544787

SN - 1522-8517

VL - 22

SP - 577

EP - 579

JO - Neuro-oncology

JF - Neuro-oncology

IS - 4

ER -

Exclusion of patients with brain metastases from cancer clinical trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this